Atai is leading a scientific demo in the United Kingdom on an ibogaine-derived treatment for opioid withdrawal and relapse avoidance.This classification is reserved for substances which have a higher prospective for abuse and no approved professional medical use in treatment in the U.S. In spite of anecdotal experiences and some preliminary studies… Read More